Radius Health Total Assets 2010-2020 | RDUS

Radius Health total assets from 2010 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Radius Health Annual Total Assets
(Millions of US $)
2019 $219
2018 $287
2017 $462
2016 $340
2015 $482
2014 $108
2013 $13
2012 $25
2011 $64
2010 $19
2009 $0
Radius Health Quarterly Total Assets
(Millions of US $)
2020-06-30 $175
2020-03-31 $202
2019-12-31 $219
2019-09-30 $227
2019-06-30 $244
2019-03-31 $265
2018-12-31 $287
2018-09-30 $319
2018-06-30 $357
2018-03-31 $404
2017-12-31 $462
2017-09-30 $507
2017-06-30 $239
2017-03-31 $295
2016-12-31 $340
2016-09-30 $378
2016-06-30 $409
2016-03-31 $445
2015-12-31 $482
2015-09-30 $506
2015-06-30 $228
2015-03-31 $247
2014-12-31 $108
2014-09-30 $71
2014-06-30 $81
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2012-12-31 $25
2011-12-31 $64
2010-12-31 $19
2009-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.560B $0.173B
Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the prevention of fractures in post-menopausal women at risk of fracture from osteoporosis. Radius Health Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.437B 43.48
Takeda Pharmaceutical (TAK) Japan $58.988B 10.28
Astellas Pharma (ALPMY) Japan $28.765B 14.58
Eisai (ESALY) Japan $26.988B 22.81
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $19.393B 25.43
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.930B 45.39
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $11.111B 13.58
Neurocrine Biosciences (NBIX) United States $9.479B 36.70
IPSEN SA ADR (IPSEY) France $9.085B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.870B 13.02
Ionis Pharmaceuticals (IONS) United States $7.179B 45.48
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.694B 10.85
Arrowhead Pharmaceuticals (ARWR) United States $4.409B 0.00
FibroGen (FGEN) United States $4.022B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
ChemoCentryx (CCXI) United States $3.810B 0.00
Nektar Therapeutics (NKTR) United States $3.608B 0.00
Hypermarcas (HYPMY) Brazil $3.528B 12.98
Sage Therapeutics (SAGE) United States $3.246B 0.00
PTC Therapeutics (PTCT) United States $3.197B 0.00
Pacira BioSciences (PCRX) United States $2.597B 68.28
Xencor (XNCR) United States $2.463B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.219B 10.74
Corcept Therapeutics (CORT) United States $2.079B 19.14
Revolution Medicines (RVMD) United States $2.040B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 0.00
Cronos Group (CRON) Canada $1.851B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.600B 11.11
USANA Health Sciences (USNA) United States $1.584B 14.92
Heron Therapeutics (HRTX) United States $1.479B 0.00
Trillium Therapeutics (TRIL) Canada $1.353B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.342B 12.80
Zogenix (ZGNX) United States $1.342B 0.00
Karyopharm Therapeutics (KPTI) United States $1.199B 0.00
Indivior (INVVY) United States $1.163B 14.42
Theravance Biopharma (TBPH) Cayman Islands $1.140B 0.00
Translate Bio (TBIO) United States $1.097B 0.00
Esperion Therapeutics (ESPR) United States $1.091B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.927B 577.00
VAXART, INC (VXRT) United States $0.898B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Endo (ENDP) Ireland $0.749B 1.11
Spectrum Pharmaceuticals (SPPI) United States $0.714B 0.00
ImmunoGen (IMGN) United States $0.710B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.708B 0.00
Collegium Pharmaceutical (COLL) United States $0.698B 0.00
Tilray (TLRY) Canada $0.679B 0.00
Molecular Templates (MTEM) United States $0.615B 0.00
Flexion Therapeutics (FLXN) United States $0.591B 0.00
Siga Technologies (SIGA) United States $0.583B 62.17
Ocular Therapeutix (OCUL) United States $0.582B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.570B 0.00
Aerie Pharmaceuticals (AERI) United States $0.567B 0.00
Ardelyx (ARDX) United States $0.540B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.519B 0.00
Harpoon Therapeutics (HARP) United States $0.466B 0.00
Altimmune (ALT) United States $0.465B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.417B 20.80
Akebia Therapeutics (AKBA) United States $0.401B 0.00
MEI Pharma (MEIP) United States $0.398B 0.00
TherapeuticsMD (TXMD) United States $0.395B 0.00
Redhill Biopharma (RDHL) Israel $0.372B 0.00
DURECT (DRRX) United States $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.348B 8.62
Jounce Therapeutics (JNCE) United States $0.336B 15.89
IMV INC (IMV) Canada $0.332B 0.00
PROFOUND MEDICL (PROF) Canada $0.329B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.304B 0.00
Xeris Pharmaceuticals (XERS) United States $0.293B 0.00
Rafael Holdings (RFL) United States $0.280B 0.00
Calithera Biosciences (CALA) United States $0.270B 0.00
Lannett Co Inc (LCI) United States $0.257B 5.96
KalVista Pharmaceuticals (KALV) United States $0.247B 0.00
Nature's Sunshine Products (NATR) United States $0.246B 24.25
Oasmia Pharmaceutical AB (OASMY) Sweden $0.229B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.220B 0.00
Heat Biologics (HTBX) United States $0.209B 0.00
Nivalis Therapeutics (ALPN) United States $0.206B 0.00
CASI Pharmaceuticals (CASI) United States $0.201B 0.00
OptiNose (OPTN) United States $0.199B 0.00
Otonomy (OTIC) United States $0.191B 0.00
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.160B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.155B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.108B 0.00
Aclaris Therapeutics (ACRS) United States $0.108B 0.00
Lipocine (LPCN) United States $0.106B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Biomerica (BMRA) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
CTI BioPharma (CTIC) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Novan (NOVN) United States $0.073B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Recro Pharma (REPH) United States $0.059B 0.00
Onconova Therapeutics (ONTX) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.27
India Globalization Capital (IGC) United States $0.049B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.049B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
ProPhase Labs (PRPH) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.09
AgeX Therapeutics (AGE) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Sundial Growers (SNDL) Canada $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 24.36
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00